Full-Time

Semiconductor Facilities & Equipment Engineer

Confirmed live in the last 24 hours

Science

Science

201-500 employees

Develops advanced biotech and high-tech products

Consulting
Industrial & Manufacturing
Biotechnology

Senior, Expert

No H1B Sponsorship

North Carolina, USA

Candidates must be US citizens or US permanent residents.

US Citizenship Required

Category
Microelectronics Engineering
Electrical Engineering

You match the following Science's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Familiarity and experience with semiconductor equipment for photolithography, RIE, thin-film deposition, LPCVD/diffusion, electroplating, and more.
  • Exceptional problem solving ability and deep technical knowledge.
  • Extensive mechanical and electrical experience.
  • A self-starter who develops innovative and efficient ways to accomplish tasks.
  • Must possess excellent written and verbal communication skills.
Responsibilities
  • Lead a small team of equipment engineers to effectively prioritize and field all equipment-related needs.
  • Manage semiconductor equipment procurement, installation, and maintenance.
  • Complete basic facilities installations, including vacuum lines, process gases piping, process cooling water, vacuum pump & chiller hook-ups.
  • Coordinate with subcontractors on more complex installations, including air handling systems, exhaust infrastructure, electrical, toxic gas monitoring systems, acid waste neutralization systems, and more.
  • Troubleshoot and repair a variety of electrical and electronic systems, including motor control systems, contactors, starters, AC/DC drives and motors, various control switches and proximity sensors utilized on production machinery.
  • Interpret electrical schematics and flow charts.
  • Place orders through procurement for spare parts and replacement parts, and complete all required documentation.
  • Support and participate in the organization’s Continuous Improvement Program to meet ISO 9001:2015 requirements by adhering to the Quality Policy and procedures and meeting QMS objectives.
  • Ensure compliance of all Company policies and OSHA rules while conducting work functions.
  • Perform other duties as assigned.
Desired Qualifications
  • B.S. or M.S. in Mechanical or Electrical Engineering (or related field), with 5 to 10 years experience in MEMS/semiconductor/process engineering, or an equivalent combination of education and experience.
  • Experience with facilities infrastructure, including HVAC, process cooling water, electrical, etc.
  • Exposure to a production cleanroom environment.
  • Experience working in an ISO 9001:2015 environment.

Science.xyz develops specialized products and services in the biotech and high-tech sectors, focusing on areas like synthetic biology, stem cell research, microfabrication, and semiconductor devices. Their products work by utilizing advanced scientific research and technology to provide solutions tailored to the needs of academic institutions, research labs, and biotech companies. What sets Science.xyz apart from its competitors is its strong emphasis on collaboration and partnerships within the scientific community, as well as its team of skilled professionals who drive their research and development efforts. The company's goal is to create valuable scientific solutions that contribute to advancements in technology and improve outcomes in various scientific fields.

Company Size

201-500

Company Stage

Seed

Total Funding

$25.3M

Headquarters

Alameda, California

Founded

2021

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for wireless neural devices boosts Science's SciFi headstage and Synapse protocol.
  • Acquisition of Pixium's PRIMA implant aligns with bioelectronics and neural interface trends.
  • Experienced executives in financial and legal roles support strategic scaling and IP management.

What critics are saying

  • Intellectual property disputes may arise from Pixium's PRIMA retinal implant acquisition.
  • New executive team integration may lead to strategic misalignments or transitional challenges.
  • Biohybrid neural interfaces face ethical and regulatory scrutiny, delaying market entry.

What makes Science unique

  • Science focuses on unmet medical needs with advanced biotech and high-tech solutions.
  • The company integrates bioelectronics with neural interfaces for vision restoration.
  • Science's strategic location in Alameda offers access to the thriving Bay Area tech market.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Flexible Vacation

Paid Parental Leave

Paid Sick Leave

401(k) Retirement Plan

Dependent Care Flexible Spending Account

Flexible Spending Account

Growth & Insights and Company News

Headcount

6 month growth

6%

1 year growth

10%

2 year growth

10%
Science.xyz
Nov 23rd, 2024
Biohybrid neural interfaces: an old idea enabling a completely new space of possibilities

At Science, Science Corp. is developing a biohybrid probe technology using highly engineered, stem cell-derived neurons embedded in vitro in electronics and engrafted into the brain, forming new biological connections.

Savills
Nov 6th, 2024
Raleigh-Durham Q3 2024 Life Sciences Market Report

Trinity Capital will build move-in ready lab space on a full floor of the recently opened Roxboro office tower in Durham to boost leasing activity.

Science.xyz
Sep 30th, 2024
Synapse: Flexible, Powerful Standard API for Neural Interface Devices

Today Science Corp. is releasing two separate but related technologies: the SciFi wireless headstage and the Synapse protocol which is spoken by all of Science's neural interface devices.

North Carolina Biotechnology Center
Aug 22nd, 2024
Science Corp. set to expand RTP facility

Science Corp. acquired the technology from Paris-based Pixium Vision SA in April.

Science.xyz
Aug 7th, 2024
Science Corporation Welcomes Tricia Gugler as Chief Financial Officer, Alex Feerst as Chief Legal Officer, and Joe Mornin as General Counsel

Science Corporation welcomes Tricia Gugler as Chief Financial Officer, Alex Feerst as Chief Legal Officer, and joe Mornin as General Counsel.

U.S. Securities and Exchange Commission
Jun 8th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Business Wire
Apr 25th, 2024
Science Corporation Acquiert L’Implant Rétinal Prima De Pixium, Renforçant Et Diversifiant Ainsi Son Engagement En Faveur De La Restauration De La Vision Grâce À Sa Technologie Dinterface Neuronale Directe

ALAMEDA, CALIFORNIE--(BUSINESS WIRE)--Science Corporation (« Science »), leader de la technologie d'interface neuronale directe (« IND ») et développeur de Science Eye, a fait l’acquisition des droits de PI et des actifs associés pour l’implant rétinien PRIMA, développé par Pixium Vision SA (« Pixium »), société de technologie IND bioélectronique. La transaction a été annoncée dans un article de blog scientifique par le PDG et cofondateur Max Hodak, qui a déclaré : « L'implant rétinien PRIMA, développé par Pixium et basé sur des recherches menées à l'université de Stanford, est très prometteur. Les premiers résultats des essais cliniques sont impressionnants. Ce dispositif, ainsi que le travail effectué sur Science Eye par Science, représentent désormais deux grandes opportunités de développement de la technologie IND visant une potentielle restauration de la vision chez des patients souffrant d’une perte de vision sévère. Nous nous engageons à apporter aux patients une restauration cliniquement significative de leur vision le plus rapidement possible. »

Business Wire
Apr 25th, 2024
Science Corporation Acquires Pixium’S Prima Retinal Implant, Extending And Diversifying Its Commitment To Vision Restoration Through Brain-Computer Interface Technology

ALAMEDA, Calif.--(BUSINESS WIRE)--Science Corporation (“Science”), a leader in brain-computer interface (“BCI”) technology and the developer of the Science Eye, has acquired the IP and related assets for the PRIMA retinal implant, developed by Pixium Vision SA (“Pixium”) of France, a bioelectronics BCI technology company. The transaction was announced in a Science blog post by CEO and co-founder Max Hodak, who said: “The PRIMA retinal implant, developed by Pixium and based on research done at Stanford University, shows great promise. The early clinical trial results we’ve seen are impressive. Together with the work being done at Science on the Science Eye, we now have two great opportunities to develop BCI technology for the potential restoration of vision in certain patients with severe vision loss. We are committed to bringing meaningful restoration of vision to patients as quickly as possible.”. Lloyd Diamond, outgoing CEO of Pixium, added: “I am thrilled to see our projects at Pixium going to Science, and in the hands of the outstanding scientists and engineers who are part of their team

AV
Nov 3rd, 2023
TechBio Portfolio Investments | Artis Ventures

Companies the firm has backed include Modern Meadow, Excision Bio, Locus Biosciences, Eko, Aether, and Freenome among others.